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yncope Management From
mergency Department
o Hospital*
ichele Brignole, MD,†
in K. Shen, MD, FACC‡
avagna, Italy; and Rochester, Minnesota
here are two main reasons for evaluating a patient with
yncope. The first reason is to make a diagnosis, that is, to
efine the mechanism that caused loss of consciousness.
he vast majority of these patients have a disturbing or
isabling condition that is not immediately life-threatening
ut may diminish quality of life and lead to physical injury.
efining the mechanism is the prerequisite for finding a
pecific therapy to prevent syncopal recurrences. The treat-
ent of syncope frequently differs from the treatment of the
nderlying disease. Therapy should be aimed either at
liminating the cause of syncope or curing the underlying
isease that predisposes to syncope. Therapeutic decisions
n both situations greatly depend on the estimation of the
elative prognostic significance that physicians attribute to
yncope and to underlying disease.
See page 276
The second reason is to determine the prognosis, that is,
o stratify the risk of future adverse clinical events to which
he patient is subject either directly related to syncope or
ore generally related to the underlying disease, of which
yncope may be only an ominous finding or one of the
linical manifestations. Physicians should be aware not to
onfound the prognostic significance of syncope with that of
he underlying disease.
Frequently, the emergency department (ED) evaluation
f a patient presenting with syncope does not reveal a clear
tiology. The emergency physician must then determine
hich patients require further diagnostic evaluation and
onitoring and in what setting, whether in hospitals or
utpatient clinics. The role and responsibility of the emer-
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †Department of Cardiology and Arrhythmologic Center, Ospedali delt
igullio, Lavagna, Italy; and the ‡Division of Cardiovascular Diseases, Department of
nternal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.ency physician in evaluating the patient with syncope has
xpanded from efforts to determine a specific cause of
yncope (diagnosis) to that of risk stratification and clinical
utcomes (prognosis), similar to the process of chest pain
valuation (1). Once the ED evaluation is completed,
ubsequent optimal patient management (by whom and
here) remains a subject of frequent debate. A validated
tandardized triage pathway has not been established. The
rticle by Constantino et al. (2) in this issue of the Journal
resents valuable prognostic information potentially useful
o the design of a standardized syncope management path-
ay. In this editorial, we would like to briefly discuss some
ecent clinical evidence, including the information pre-
ented by Constantino et al. (2), with a friendly intent to
hallenge the authors of the article and readers of the Journal
ith a proposed novel syncope model/facility to ultimately
mprove the efficiency and effectiveness of managing this
arge and difficult patient population.
anagement of Risk
hort-term (within 10 days) risk. Few studies have di-
ectly evaluated the short-term risk of syncope. The risk of
ife-threatening conditions in the few days after ED referral
s obviously the main reason for immediate hospital admis-
ion and exhaustive evaluation.
In the StePS (Short-Term Prognosis of Syncope) study
2), published in this issue of the Journal, abnormal electro-
ardiogram (ECG), concomitant trauma, absence of symp-
oms of impending syncope, and male gender were associ-
ted with 10 days’ higher risk of death or serious adverse
vents (defined as cardiopulmonary resuscitation, pace-
aker or defibrillator implant, and intensive care unit
dmittance) and early readmission to a hospital. However,
wing to the relatively low rate of these events, their clinical
tility was hampered by a very low positive predictive value
hat ranged between 11% and 14%.
The San Francisco Syncope Rule (3) considers patients
ith an abnormal ECG, a complaint of shortness of breath,
ematocrit 30%, systolic blood pressure 90 mm Hg, or
history of congestive heart failure. The rule was 98%
ensitive and 56% specific to predict serious outcomes
ithin 7 days of ED presentation (defined as death, myo-
ardial infarction, arrhythmia, pulmonary embolism, stroke,
ubarachnoid hemorrhage, significant hemorrhage, or any
ondition causing a return ED visit and hospitalization).
owever, in 1 external validation cohort (4), the San
rancisco Syncope Rule had a lower sensitivity and speci-
city than in previous reports (89% and 42%).
Both studies have shown that the risk of death and of
dverse outcome is high in the few days following the index
yncopal episode among high-risk patients, thus justifying
he effort for identification and immediate hospitalization
ith intensive management of these patients. Most of the
eaths and many detrimental outcomes seemed to be related
o the severity of the underlying disease rather than to
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January 22, 2008:284–7 Editorial Commentyncope per se. For example, in the STePS study, 5 patients
0.7%) died; the causes of death were disseminated intra-
ascular coagulation, acute pulmonary edema, aortic dis-
ection, pulmonary embolism, and stroke. Similarly, in
GSYS (Evaluation of Guidelines in Syncope Study) (5),
0 patients (1%) died before discharge: sudden death in 1
ase, cardiac nonsudden death in 3 cases, pulmonary
isease in 2 cases, cancer in 3 cases, and undefined in 1
ase.
The recommendations for hospitalization from the recent
olicy statement of the American College of Emergency
hysicians (1), targeting ED patients without an established
iagnosis, are based primarily on the evaluation of risk; they
re summarized in Table 1.
ong-term (1-year) risk. In the STePS study (2), long-
erm severe outcome was correlated with an age 65 years
nd history of neoplasms, cerebrovascular diseases, struc-
ural heart diseases, and ventricular arrhythmias. This find-
ng is likely to reflect the importance of comorbidities, as
uggested by long-term risk factors such as cardiac and
erebrovascular diseases and neoplasms.
Martin et al. (6) studied 252 syncope patients to develop
risk classification system and then tested the system in a
alidation cohort of 374 patients. Predictors of arrhythmia
r 1-year mortality in the validation cohort were found to be
bnormal ECG result, history of ventricular arrhythmia,
istory of congestive heart failure, or age 45 years. The
vent rate (clinically significant arrhythmia or death) at 1
ear ranged from 0% for those with none of the 4 risk factors
o 27% for those with 3 or 4 risk factors.
For the OESIL (Osservatorio Epidemiologico della Sin-
ope nel Lazio) risk score (7), mortality increased signifi-
antly within 1 year in patients with age 65 years, history
f cardiovascular disease, lack of prodromes, and abnormal
lectrocardiogram (0% for no factor, 0.8% for 1 factor,
9.6% for 2 factors, 34.7% for 3 factors, and 57.1% for 4
actors).
Again, similar to the short-term events, most of the
eaths and serious outcomes seemed to be correlated to the
everity of the underlying disease rather than to syncope per
e. High-risk patients need to be followed closely; optimal
herapy and management must be provided. However,
actors That Lead to Stratification as High-Riskor Adverse Outcome (Hosp tal Admissione ommended) Used in the Cl nic l Policy ofhe A ic n Colleg of Emergency Physic ans (1)
Table 1
Factors That Lead to Stratification as High-Risk
for Adverse Outcome (Hospital Admission
Recommended) Used in the Clinical Policy of
the American College of Emergency Physicians (1)
● Older age and associated comorbidities*
● Abnormal electrocardiogram (including acute ischemia, dysrhythmias, or
significant conduction abnormalities)
● Hematocrit 30% (if obtained)
● History or presence of heart failure, coronary artery disease, or structural heart
disease
Different studies use different ages as threshold for decision-making. Age is likely a continuous
ariable that reflects the cardiovascular health of the individual rather than being an arbitrary
alue.he presumption that an immediate in-hospital evalua- Eion improves a patient’s long-term clinical outcome has
ever been demonstrated, and alternative strategies could
e considered.
anagement (Diagnosis and Treatment) of Syncope
ontrary to the recommendations of the American College
f Emergency Physicians that are based on the evaluation of
isk stratification, the recommendations for hospitalization
rom the Guidelines on Syncope of the European Society of
ardiology (8) are based on the evaluation of the mecha-
ism of syncope and of its treatment. The recommendations
re summarized in Table 2.
new proposed model of syncope management (role of
yncope facilities). A recent randomized, single-center
tudy, SEEDS (Syncope Evaluation in the Emergency
epartment Study) (9), showed that a syncope observa-
ional unit in the ED, with appropriate resources and a
ultidisciplinary collaboration, could improve the diagnos-
ic yield, reduce hospital admission, and achieve favorable
ong-term outcome in survival and recurrent symptoms of
yncope. After initial assessment with a complete history,
hysical examination, and standard ECG, the patients
eceived continuous cardiac telemetry for up to 6 h,
ourly vital signs and orthostatic blood pressure checks,
nd echocardiogram for patients with abnormal cardio-
ascular examination or electrocardiographic findings.
ilt-table testing, carotid sinus massage, and electro-
hysiology consultations (and other subspecialties) were
ade available to the ED physician. After completion of
yncope observational unit evaluation, follow-up appoint-
ospital Admission for Syncope Managementecommended by the ESC Syncope Guideli es (8)
Table 2 Hospital Admission for Syncope ManagementRecommended by the ESC Syncope Guidelines (8)
For diagnosis
Strongly recommended
● Suspected or known significant heart disease
● Electrocardiographic abnormalities suggestive of arrhythmic syncope
● Syncope occurring during exercise
● Syncope causing severe injury
● Strong family history of sudden death
Occasionally may need to be admitted
● Patients with or without heart disease but with:
Œ sudden onset of palpitations shortly before syncope
Œ syncope in supine position
Œ worrisome family history
Œ significant physical injury
● Patients with minimal or mild heart disease when there is high suspicion for
cardiac syncope
● Suspected pacemaker or implantable cardioverter-defibrillator problem
For treatment
● Cardiac arrhythmias as cause of syncope
● Syncope due to cardiac ischaemia
● Syncope secondary to the structural cardiac or cardiopulmonary diseases
● Stroke or focal neurologic disorders
● Cardioinhibitory neurally mediated syncope when a pacemaker implantation
is plannedSC  European Society of Cardiology.
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Editorial Comment January 22, 2008:284–7ent at the outpatient syncope management unit can be
rranged, when needed, if the patient is not to be admitted
o the hospital.
Following hospital admission, concerns that “well-
ppearing” syncope patients may have a “malignant” or
dverse outcome frequently result in extensive broad-based
valuations that are often deemed unnecessary and cost-
neffective (10–14). A recent prospective study, EGSYS-2
15,16), evaluated a new method of management of syncope
ased on a decision-making approach developed in strict
dherence to the recommendations of the guidelines of the
uropean Society of Cardiology (8). To maximize its
pplication, decision-making guideline-based software was
sed, and trained core medical personnel were designated,
oth locally in each hospital and centrally, to verify adher-
nce to the diagnostic pathway and give advice on its
orrection. The study showed that this standardized care
athway significantly improved diagnostic yield and reduced
ospital admissions, resource consumption, and overall costs
ompared with usual care.
Although the results of SEEDS and EGSYS-2 studies
re difficult to reproduce in everyday practice, these results
re encouraging preliminary evidence that supports the
otion that a designated syncope management unit, in the
D and/or at a hospital, can provide more efficient and
ffective triage and evaluation of patients in selected centers.
he general strategy in a specialized syncope management
Figure 1 A Proposed Syncope Management Model From Emerg
*The 6-h ED syncope unit evaluation was examined and validated in the SEEDS st
2 factors. Within 24 h, the medical team should decide whether the patient will ne
and outpatient management. When a hospital stay is 24 h, the patient can be m
reducing health care resource utilization. **The Syncope Management Unit was
European Society of Cardiology (8) and validated in the EGSYS-2 studies (15,16).
ER  emergency room; ESC  European Society of Cardiology.nit concept is proposed in Figure 1.Several critical questions remain to be addressed. Is the
yncope unit model/critical pathway implemented in
EEDS suitable only in large referral centers with sufficient
esources such as continuous monitoring, availability of
ardiac and tilt-table testing, and immediate consultations
rom electrophysiologists, cardiologists, neurologists, or
ther subspecialists? Can the training and educational ef-
orts made by the medical staff in EGSYS-2 be successfully
mplemented in other hospitals? Should a more “basic”
yncope management model suitable for most community
ospitals be examined? What additional clinical outcome
ata may be required to validate a standardized syncope unit
ractice model that can be widely adapted in all hospital
ractices? Defining and managing the syncope patient will
ontinue to be a challenge. We anticipate that the syncope
anagement unit concept will continue to evolve and to be
efined with additional evidence, such as that presented by
onstantino et al. (2), to eventually provide the optimal
atient care.
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